Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,002,995
  • Shares Outstanding, K 110,462
  • Annual Sales, $ 0 K
  • Annual Income, $ -192,410 K
  • EBIT $ -260 M
  • EBITDA $ -263 M
  • 60-Month Beta 1.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.86

Options Overview Details

View History
  • Implied Volatility 196.66% ( +16.94%)
  • Historical Volatility 66.46%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 196.66% on 11/20/24
  • IV Low 11.59% on 09/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 53
  • Volume Avg (30-Day) 424
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 7,970
  • Open Int (30-Day) 7,222

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.59
  • Number of Estimates 7
  • High Estimate -0.51
  • Low Estimate -0.67
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +6.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.56 +5.02%
on 11/18/24
12.61 -28.71%
on 10/23/24
-2.87 (-24.20%)
since 10/21/24
3-Month
8.56 +5.02%
on 11/18/24
12.61 -28.71%
on 10/23/24
-1.25 (-12.21%)
since 08/21/24
52-Week
3.67 +144.96%
on 12/11/23
12.61 -28.71%
on 10/23/24
+2.11 (+30.67%)
since 11/21/23

Most Recent Stories

More News
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics

COGT : 8.98 (-1.10%)
Markets Today: Stocks Slightly Higher on Strength in Tesla and Netflix

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.11%. U.S. stock index futures this morning are slightly higher. Tesla...

ESZ24 : 5,968.00 (+0.51%)
NQZ24 : 20,798.25 (+0.24%)
TSLA : 339.64 (-0.70%)
NFLX : 897.48 (+1.54%)
PLAY : 34.10 (-0.44%)
AMZN : 198.38 (-2.22%)
YEXT : 7.95 (+2.58%)
SMCI : 29.70 (+15.12%)
NVCR : 17.09 (+1.36%)
CASY : 416.40 (+0.59%)
BASE : 21.02 (+3.09%)
UNFI : 23.61 (+3.37%)
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results

On-track to present additional data from Phase 2 APEX trial by the end of 2022 Initial data from Phase 2 SUMMIT trial & lead-in data from Phase 3...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass. and BOULDER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

COGT : 8.98 (-1.10%)
Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

All patients treated with bezuclastinib achieved ≥50% reduction in serum tryptase, with a median reduction of 89%, regardless of prior KIT D816V inhibitor...

COGT : 8.98 (-1.10%)
Cogent Biosciences to Host Investor Webcast on June 10, 2022 at 8:00am ET

– Event to review initial clinical data from APEX, a Phase 2 trial with bezuclastinib in Advanced Systemic Mastocytosis presented at European Hematology...

COGT : 8.98 (-1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 9.65
2nd Resistance Point 9.47
1st Resistance Point 9.28
Last Price 8.98
1st Support Level 8.91
2nd Support Level 8.73
3rd Support Level 8.54

See More

52-Week High 12.61
Fibonacci 61.8% 9.19
Last Price 8.98
Fibonacci 50% 8.14
Fibonacci 38.2% 7.09
52-Week Low 3.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar